PMID- 20178741 OWN - NLM STAT- MEDLINE DCOM- 20100323 LR - 20211203 IS - 1097-4172 (Electronic) IS - 0092-8674 (Print) IS - 0092-8674 (Linking) VI - 140 IP - 4 DP - 2010 Feb 19 TI - Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. PG - 477-90 LID - 10.1016/j.cell.2010.01.029 [doi] AB - Current models imply that the FERM domain protein Merlin, encoded by the tumor suppressor NF2, inhibits mitogenic signaling at or near the plasma membrane. Here, we show that the closed, growth-inhibitory form of Merlin accumulates in the nucleus, binds to the E3 ubiquitin ligase CRL4(DCAF1), and suppresses its activity. Depletion of DCAF1 blocks the promitogenic effect of inactivation of Merlin. Conversely, enforced expression of a Merlin-insensitive mutant of DCAF1 counteracts the antimitogenic effect of Merlin. Re-expression of Merlin and silencing of DCAF1 implement a similar, tumor-suppressive program of gene expression. Tumor-derived mutations invariably disrupt Merlin's ability to interact with or inhibit CRL4(DCAF1). Finally, depletion of DCAF1 inhibits the hyperproliferation of Schwannoma cells from NF2 patients and suppresses the oncogenic potential of Merlin-deficient tumor cell lines. We propose that Merlin suppresses tumorigenesis by translocating to the nucleus to inhibit CRL4(DCAF1). CI - 2010 Elsevier Inc. All rights reserved. FAU - Li, Wei AU - Li W AD - Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. FAU - You, Liru AU - You L FAU - Cooper, Jonathan AU - Cooper J FAU - Schiavon, Gaia AU - Schiavon G FAU - Pepe-Caprio, Angela AU - Pepe-Caprio A FAU - Zhou, Lu AU - Zhou L FAU - Ishii, Ryohei AU - Ishii R FAU - Giovannini, Marco AU - Giovannini M FAU - Hanemann, C Oliver AU - Hanemann CO FAU - Long, Stephen B AU - Long SB FAU - Erdjument-Bromage, Hediye AU - Erdjument-Bromage H FAU - Zhou, Pengbo AU - Zhou P FAU - Tempst, Paul AU - Tempst P FAU - Giancotti, Filippo G AU - Giancotti FG LA - eng SI - GEO/GSE19305 GR - P30 CA008748/CA/NCI NIH HHS/United States GR - P30 CA008748-44/CA/NCI NIH HHS/United States GR - R01 CA098210/CA/NCI NIH HHS/United States GR - P30 CA08748/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell JT - Cell JID - 0413066 RN - 0 (Carrier Proteins) RN - 0 (Neurofibromin 2) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.11.1 (DCAF1 protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) SB - IM MH - Active Transport, Cell Nucleus MH - Animals MH - Carrier Proteins/chemistry/*metabolism MH - Cell Line MH - Cell Line, Tumor MH - Cell Proliferation MH - Cells, Cultured MH - *Genes, Tumor Suppressor MH - Humans MH - Mesothelioma/*metabolism MH - Models, Molecular MH - Neurilemmoma/*metabolism MH - Neurofibromin 2/*metabolism MH - Protein Serine-Threonine Kinases MH - Ubiquitin-Protein Ligases PMC - PMC2828953 MID - NIHMS175286 EDAT- 2010/02/25 06:00 MHDA- 2010/03/24 06:00 PMCR- 2011/02/19 CRDT- 2010/02/25 06:00 PHST- 2009/01/22 00:00 [received] PHST- 2009/08/07 00:00 [revised] PHST- 2010/01/16 00:00 [accepted] PHST- 2010/02/25 06:00 [entrez] PHST- 2010/02/25 06:00 [pubmed] PHST- 2010/03/24 06:00 [medline] PHST- 2011/02/19 00:00 [pmc-release] AID - S0092-8674(10)00064-4 [pii] AID - 10.1016/j.cell.2010.01.029 [doi] PST - ppublish SO - Cell. 2010 Feb 19;140(4):477-90. doi: 10.1016/j.cell.2010.01.029.